Ellington Management Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-17,300
Closed -$102K 778
2019
Q3
$102K Buy
+17,300
New +$102K 0.02% 532
2017
Q2
Sell
-19,000
Closed -$324K 955
2017
Q1
$324K Buy
+19,000
New +$324K 0.01% 430